Brokerages Set Trupanion, Inc. (NASDAQ:TRUP) Target Price at $36.17

Shares of Trupanion, Inc. (NASDAQ:TRUP) have received a consensus recommendation of “Moderate Buy” from the seven analysts that are currently covering the company, Marketbeat reports. Three research analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company. The average 1-year target price among brokers that have covered the stock in the last year is $36.17.

A number of research firms recently weighed in on TRUP. Piper Sandler upped their price target on Trupanion from $30.00 to $38.00 and gave the stock a “neutral” rating in a report on Friday, August 9th. Evercore ISI raised Trupanion to a “strong-buy” rating in a report on Friday, August 9th. William Blair began coverage on Trupanion in a research note on Friday, July 19th. They set an “outperform” rating for the company. Northland Securities boosted their price objective on Trupanion from $30.00 to $35.00 and gave the stock a “market perform” rating in a research note on Friday, August 9th. Finally, Stifel Nicolaus reiterated a “hold” rating and set a $30.00 price objective (up from $22.00) on shares of Trupanion in a research note on Friday, August 9th.

Trupanion Stock Performance

Shares of TRUP stock opened at $42.87 on Thursday. The stock has a market cap of $1.81 billion, a PE ratio of -66.98 and a beta of 1.74. Trupanion has a 52-week low of $19.14 and a 52-week high of $48.85. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.42. The business has a 50-day simple moving average of $37.74 and a 200-day simple moving average of $30.62.

Trupanion (NASDAQ:TRUP) last released its quarterly earnings results on Thursday, August 8th. The financial services provider reported ($0.14) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.18) by $0.04. The company had revenue of $314.80 million during the quarter, compared to analysts’ expectations of $309.33 million. Trupanion had a negative return on equity of 6.29% and a negative net margin of 1.57%. Trupanion’s quarterly revenue was up 16.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted ($0.33) EPS. On average, equities analysts expect that Trupanion will post -0.37 EPS for the current year.

Insider Activity

In other news, CEO Margaret Tooth sold 7,500 shares of the company’s stock in a transaction that occurred on Wednesday, August 28th. The stock was sold at an average price of $46.48, for a total value of $348,600.00. Following the completion of the sale, the chief executive officer now directly owns 99,984 shares in the company, valued at $4,647,256.32. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other news, CEO Margaret Tooth sold 7,500 shares of the company’s stock in a transaction that occurred on Wednesday, August 28th. The stock was sold at an average price of $46.48, for a total value of $348,600.00. Following the completion of the sale, the chief executive officer now directly owns 99,984 shares in the company, valued at $4,647,256.32. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Fawwad Qureshi sold 624 shares of the company’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $46.54, for a total value of $29,040.96. The disclosure for this sale can be found here. Insiders sold 8,764 shares of company stock worth $405,238 over the last ninety days. Corporate insiders own 5.50% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. Quest Partners LLC purchased a new position in Trupanion in the fourth quarter worth approximately $67,000. Headlands Technologies LLC purchased a new position in Trupanion in the second quarter worth approximately $162,000. Victory Capital Management Inc. purchased a new position in Trupanion in the fourth quarter worth approximately $211,000. Blueshift Asset Management LLC purchased a new position in Trupanion in the fourth quarter worth approximately $220,000. Finally, Oppenheimer Asset Management Inc. purchased a new position in Trupanion in the second quarter worth approximately $235,000.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.